Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies

Head & Neck ◽  
2005 ◽  
Vol 27 (5) ◽  
pp. 406-414 ◽  
Author(s):  
Noel M. Kramer ◽  
Eric M. Horwitz ◽  
Jonathan Cheng ◽  
John A. Ridge ◽  
Steven J. Feigenberg ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Phase I ◽  
Head And Neck ◽  
Neck Cancer ◽  
Outcome Analysis ◽  
Prospective Phase ◽  
Recurrent Head ◽  
Phase I And Ii

Combined effect of genetic polymorphisms in phase I and II biotransformation enzymes on head and neck cancer risk

Head & Neck ◽  
2012 ◽  
Vol 35 (6) ◽  
pp. 858-867 ◽  
Author(s):  
Martin Lacko ◽  
Adri C. Voogd ◽  
Hennie M. J. Roelofs ◽  
Rene H. M. te Morsche ◽  
Michel B. Oude Ophuis ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Cancer Risk ◽  
Phase I ◽  
Head And Neck ◽  
Genetic Polymorphisms ◽  
Neck Cancer ◽  
Combined Effect ◽  
Biotransformation Enzymes ◽  
Phase I And Ii

scholarly journals 921P Pembrolizumab plus docetaxel for the treatment of recurrent metastatic head and neck cancer: A prospective phase I/II study

2020 ◽  
Vol 31 ◽  
pp. S665
Author(s):  
T. Fuereder ◽  
C. Minichsdorfer ◽  
M. Mittlboeck ◽  
C. Wagner ◽  
F. Oberndorfer ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Phase I ◽  
Head And Neck ◽  
Neck Cancer ◽  
Prospective Phase

Phase I Study of S-1 plus Nedaplatin in Patients with Advanced/Recurrent Head and Neck Cancer

Chemotherapy ◽  
2010 ◽  
Vol 56 (6) ◽  
pp. 453-458 ◽  
Author(s):  
Yasunao Kogashiwa ◽  
Kohichi Yamauchi ◽  
Hiroshi Nagafuji ◽  
Takehiro Matsuda ◽  
Toshihito Tsubosaka ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Phase I ◽  
Head And Neck ◽  
Neck Cancer ◽  
Phase I Study ◽  
Recurrent Head

A phase I study of cisplatin, tirapazamine and accelerated re-irradiation in unresectable recurrent head and neck cancer

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 5511-5511 ◽  
Author(s):  
E. E. W. Cohen ◽  
D. Rosine ◽  
E. Loh ◽  
D. J. Haraf ◽  
E. E. Vokes ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Phase I ◽  
Head And Neck ◽  
Neck Cancer ◽  
Phase I Study ◽  
Recurrent Head

Phase I trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 5561-5561 ◽  
Author(s):  
J. Kao ◽  
S. H. Packer ◽  
M. Teng ◽  
V. Gupta ◽  
K. Misiukiewicz ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Phase I ◽  
Head And Neck ◽  
Neck Cancer ◽  
Phase I Trial ◽  
Recurrent Head

Phase I study of weekly docetaxel and cisplatin arterial infusion for recurrent head and neck cancer

Head & Neck ◽  
2011 ◽  
Vol 34 (11) ◽  
pp. 1634-1639
Author(s):  
Tatsuya Nakamura ◽  
Nobukazu Fuwa ◽  
Kanako Takayama ◽  
Haruo Inokuchi ◽  
Takuya Tomoda ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Phase I ◽  
Head And Neck ◽  
Neck Cancer ◽  
Phase I Study ◽  
Arterial Infusion ◽  
Weekly Docetaxel ◽  
Recurrent Head

Mature results of a phase I trial of bortezomib, cisplatin, and radiotherapy for advanced or recurrent head and neck cancer.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 5560-5560
Author(s):  
R. S. Axelrod ◽  
P. H. Ahn ◽  
G. J. Kubicek ◽  
P. R. Anne ◽  
D. Cognetti ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Phase I ◽  
Head And Neck ◽  
Neck Cancer ◽  
Phase I Trial ◽  
Recurrent Head
Sign in / Sign up

Export Citation Format

Share Document